STOCK TITAN

Harold Shlevin to sell 441,500 GALT common shares (NASDAQ: GALT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

GALT shareholder Harold Shlevin filed a notice to sell up to 441,500 common shares, with an aggregate market value of 1,836,640, through Merrill Lynch on NASQ around 01/02/2026. The filing lists 64,472,792 common shares outstanding for the issuer. The planned sale shares were acquired via a 6,500-share open market purchase on 12/30/2024 and multiple stock option exercises between 2018 and 2024, including 60,000 shares on 01/23/2025. In the prior three months, Shlevin sold 159,000, 16,790, 19,793, 8,417 and 24,706 common shares in December 2025, with gross proceeds ranging from 52,541.90 to 943,448.33.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many GALT shares does Harold Shlevin plan to sell under this Form 144?

The notice states that up to 441,500 common shares of GALT are to be sold, with an aggregate market value of 1,836,640.

On what exchange and through which broker are the GALT shares to be sold?

The filing lists Merrill Lynch, located at 401 E Las Olas Blvd, Fort Lauderdale, FL 33301, as broker and names NASQ as the securities exchange.

How many GALT shares are reported as outstanding in this Form 144?

The Form 144 reports 64,472,792 common shares as the number of shares or other units outstanding for the issuer.

What prior GALT stock sales by Harold Shlevin are disclosed in the past 3 months?

The filing shows December 2025 sales of 159,000, 16,790, 19,793, 8,417 and 24,706 common shares, with gross proceeds between 52,541.90 and 943,448.33.

How were the GALT shares to be sold originally acquired?

The notice lists a 6,500-share open market purchase on 12/30/2024 and several stock option exercises from the issuer on dates including 01/15/2018, 05/18/2018, 06/08/2018, 01/16/2019, 01/09/2020, 03/25/2021, 01/26/2023 and 01/24/2024.

What representation does the seller make about information on the issuer?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Galectin Therapeutics Inc

NASDAQ:GALT

GALT Rankings

GALT Latest News

GALT Latest SEC Filings

GALT Stock Data

203.09M
45.42M
30.08%
16.46%
12.47%
Biotechnology
Pharmaceutical Preparations
Link
United States
NORCROSS